Cargando…

Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours

OBJECTIVE: Stromal barriers, such as the abundant desmoplastic stroma that is characteristic of pancreatic ductal adenocarcinoma (PDAC), can block the delivery and decrease the tumour-penetrating ability of therapeutics such as tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), which...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Hsi-Chien, Sung, Yun-Chieh, Li, Chung-Pin, Wan, Dehui, Chao, Po-Han, Tseng, Yu-Ting, Liao, Bo-Wen, Cheng, Hui-Teng, Hsu, Fu-Fei, Huang, Chieh-Cheng, Chen, Yi-Ting, Liao, Yu-Hui, Hsieh, Hsin Tzu, Shih, Yu-Chuan, Liu, I-Ju, Wu, Han-Chung, Lu, Tsai-Te, Wang, Jane, Chen, Yunching
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Pancreas
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380514/ https://www.ncbi.nlm.nih.gov/pubmed/34921062 http://dx.doi.org/10.1136/gutjnl-2021-325180

Ejemplares similares

Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment
por: Wang, Liwen, et al.
Publicado: (2023)

Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
por: Yu, Jun, et al.
Publicado: (2015)

Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer
por: Goehrig, Delphine, et al.
Publicado: (2019)

Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size
por: Hackeng, Wenzel M, et al.
Publicado: (2022)

Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system
por: Hong, Xiafei, et al.
Publicado: (2020)

GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer
por: Martinelli, Paola, et al.
Publicado: (2017)

Relationship between pancreatic parenchyma loss and early postoperative hyperglycemia in patients with benign pancreatic diseases
por: Wen, Kan, et al.
Publicado: (2021)

Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours
por: Young, Kate, et al.
Publicado: (2021)

Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to fuel tumour progression
por: Ruivo, Carolina F, et al.
Publicado: (2022)

Targeting both tumour-associated CXCR2(+) neutrophils and CCR2(+) macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma
por: Nywening, Timothy M, et al.
Publicado: (2018)

Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer
por: Mahajan, Ujjwal M, et al.
Publicado: (2016)

Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis
por: de la Iglesia-García, Daniel, et al.
Publicado: (2017)

Prediction of infected pancreatic necrosis in acute necrotizing pancreatitis by the modified pancreatitis activity scoring system
por: Mao, Wenjian, et al.
Publicado: (2022)

SWI/SNF component ARID1A restrains pancreatic neoplasia formation
por: Wang, Sam C, et al.
Publicado: (2019)

Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis
por: Hart, Phil A, et al.
Publicado: (2013)

Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
por: Mayerle, Julia, et al.
Publicado: (2018)

Post‐pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes
por: Dugic, Ana, et al.
Publicado: (2022)

Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystem
por: Han, Xuexiang, et al.
Publicado: (2018)

Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms
por: Yu, Jun, et al.
Publicado: (2017)

Pancreatic enzyme treatment in chronic pancreatitis: Quality of management and adherence to guidelines–A cross‐sectional observational study
por: Erchinger, Friedemann, et al.
Publicado: (2022)

Targeting mTOR dependency in pancreatic cancer
por: Morran, Douglas C, et al.
Publicado: (2014)

UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better
por: Michl, Patrick, et al.
Publicado: (2021)

The microbiome in pancreatic diseases: Recent advances and future perspectives
por: Ammer-Herrmenau, Christoph, et al.
Publicado: (2020)

The impact of race/ethnicity on pancreaticoduodenectomy outcomes for pancreatic cancer
por: Alwatari, Yahya, et al.
Publicado: (2022)

Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase
por: Reinert, Christian Philipp, et al.
Publicado: (2020)

Desmoplasia and Chemoresistance in Pancreatic Cancer
por: Schober, Marvin, et al.
Publicado: (2014)

Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case–control study
por: Tan, Pui San, et al.
Publicado: (2023)

Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications
por: Luchini, Claudio, et al.
Publicado: (2021)

Single-cell sequencing unveils distinct immune microenvironments with CCR6-CCL20 crosstalk in human chronic pancreatitis
por: Lee, Bomi, et al.
Publicado: (2022)

SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
por: Biederstädt, Alexander, et al.
Publicado: (2020)

Structural imaging findings are related to clinical complications in chronic pancreatitis
por: Nordaas, Ingrid Kvåle, et al.
Publicado: (2022)

A faecal microbiota signature with high specificity for pancreatic cancer
por: Kartal, Ece, et al.
Publicado: (2022)

Consensus definition of sludge and microlithiasis as a possible cause of pancreatitis
por: Żorniak, Michal, et al.
Publicado: (2023)

Factors affecting the rates of adherence to surveillance recommendations for incidental pancreatic cystic lesions in a large urban safety net hospital
por: Canakis, Andrew, et al.
Publicado: (2020)

Autoimmune pancreatitis results from loss of TGFβ signalling in S100A4-positive dendritic cells
por: Boomershine, C S, et al.
Publicado: (2009)

Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma
por: Raj, Deepak, et al.
Publicado: (2019)

Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer
por: Gaiser, Rogier Aäron, et al.
Publicado: (2019)

Long-term yield of pancreatic cancer surveillance in high-risk individuals
por: Overbeek, Kasper A, et al.
Publicado: (2022)

Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype
por: Liffers, Sven-Thorsten, et al.
Publicado: (2023)

Quantitative MRI of chronic pancreatitis: results from a multi-institutional prospective study, magnetic resonance imaging as a non-invasive method for assessment of pancreatic fibrosis (MINIMAP)
por: Tirkes, Temel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cgb6o4ch43lfa4tdrudag4b9n3